Isis Pharma (ISIS) Earns $1M Milestone in HBV Collaboration with Glaxo (GSK)
Tweet Send to a Friend
Isis Pharma (NASDAQ: ISIS) has earned a $1 million payment from GlaxoSmithKline (NYSE: GSK) related to the advancement of its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
